<html>
<head>
<title>Section 318:51-c Licensing of Outsourcing Facilities Identified as Section 503B Facilities by the United States Food and Drug Administration.</title>
<!-- Hide metadata
<titlename>TITLE XXX OCCUPATIONS AND PROFESSIONS</titlename>
<chapter>CHAPTER 318 PHARMACISTS AND PHARMACIES</chapter>
<sectiontitle>Section 318:51-c Licensing of Outsourcing Facilities Identified as Section 503B Facilities by the United States Food and Drug Administration.</sectiontitle>
-->
<meta name="titlename" content="TITLE XXX OCCUPATIONS AND PROFESSIONS">
<meta name="chapter" content="CHAPTER 318 PHARMACISTS AND PHARMACIES">
<meta name="sectiontitle" content="Section 318:51-c Licensing of Outsourcing Facilities Identified as Section 503B Facilities by the United States Food and Drug Administration.">
<meta name="sourcenote" content="Source.  2015, 180:3, eff. July 1, 2015.">
<meta name="codesect" content="<br>&nbsp&nbsp&nbspI. No person shall compound legend drugs or controlled drugs, as defined in RSA 318-B:1, VI, and no person acting as or employed by an outsourcing facility shall supply such drugs, without first having obtained a license from the board.  Such license shall expire annually on June 30.  An application together with a fee established by the board shall be filed annually on or before July 1.<br>&nbsp&nbsp&nbspII. No license shall be issued under this section unless the applicant has furnished proof satisfactory to the pharmacy board:<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(a) That the applicant is of good moral character or, if that applicant is an association or corporation, that the managing officers are of good moral character.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(b) That the applicant has sufficient land, buildings, and security equipment as to properly carry on the business described in the application.<br>&nbsp&nbsp&nbspIII. No license shall be granted to any person who has within 5 years been convicted of a violation of any law of the United States, or of any state, relating to drugs, as defined in this chapter or RSA 318-B, or to any person who is a drug-dependent person.<br>&nbsp&nbsp&nbspIV. Any person licensed pursuant to this section shall be subject to the provisions of RSA 318:29.<br>&nbsp&nbsp&nbspV. (a) The outsourcing facility to which a license has been issued shall, within 30 days of any change of information supplied in the original application, notify the board.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(b) The notice required pursuant to subparagraph (a) shall contain:<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(1) Current New Hampshire license number of the outsourcing facility.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(2) Name of the outsourcing facility, old and new, if applicable.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(3) Address of the outsourcing facility, old and new, if applicable.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(4) Names, addresses, and titles of new corporate officers, partners, or owners.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(c) A new license shall be required for a change of ownership of an established outsourcing facility to a successor business entity which results in a change in the controlling interest in the outsourcing facility.<br>&nbsp&nbsp&nbspVI. The outsourcing facility to which a license has been issued shall, within 30 days of any written warnings or disciplinary action from any state or federal licensing or enforcement agency, notify the board and provide a copy of the action.">
</head>
<body>
<center><h1>TITLE XXX<br>OCCUPATIONS AND PROFESSIONS</h1></center>
<center><h2>CHAPTER 318<br>PHARMACISTS AND PHARMACIES</h2></center>
<center><h2>Possession and Sale of Drugs and Devices for Administration of Drugs</h2></center>
<center><h3>Section 318:51-c</h3></center>
&nbsp;&nbsp;&nbsp;<b> 318:51-c Licensing of Outsourcing Facilities Identified as Section 503B Facilities by the United States Food and Drug Administration. &#150;</b>
<codesect>
<br>
&nbsp&nbsp&nbsp
I. No person shall compound legend drugs or controlled drugs, as defined in RSA 318-B:1, VI, and no person acting as or employed by an outsourcing facility shall supply such drugs, without first having obtained a license from the board.  Such license shall expire annually on June 30.  An application together with a fee established by the board shall be filed annually on or before July 1.
<br>
&nbsp&nbsp&nbsp
II. No license shall be issued under this section unless the applicant has furnished proof satisfactory to the pharmacy board:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(a) That the applicant is of good moral character or, if that applicant is an association or corporation, that the managing officers are of good moral character.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) That the applicant has sufficient land, buildings, and security equipment as to properly carry on the business described in the application.
<br>
&nbsp&nbsp&nbsp
III. No license shall be granted to any person who has within 5 years been convicted of a violation of any law of the United States, or of any state, relating to drugs, as defined in this chapter or RSA 318-B, or to any person who is a drug-dependent person.
<br>
&nbsp&nbsp&nbsp
IV. Any person licensed pursuant to this section shall be subject to the provisions of RSA 318:29.
<br>
&nbsp&nbsp&nbsp
V. (a) The outsourcing facility to which a license has been issued shall, within 30 days of any change of information supplied in the original application, notify the board.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) The notice required pursuant to subparagraph (a) shall contain:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(1) Current New Hampshire license number of the outsourcing facility.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(2) Name of the outsourcing facility, old and new, if applicable.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(3) Address of the outsourcing facility, old and new, if applicable.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(4) Names, addresses, and titles of new corporate officers, partners, or owners.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(c) A new license shall be required for a change of ownership of an established outsourcing facility to a successor business entity which results in a change in the controlling interest in the outsourcing facility.
<br>
&nbsp&nbsp&nbsp
VI. The outsourcing facility to which a license has been issued shall, within 30 days of any written warnings or disciplinary action from any state or federal licensing or enforcement agency, notify the board and provide a copy of the action.
</codesect>
<sourcenote>
<p><b>Source.</b>  2015, 180:3, eff. July 1, 2015.</p>
</sourcenote>
</body>
</html>
